NCT05722951

Metformin Efficacy and Safety in Epileptic Patients

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: Tanta University · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The goal of this clinical trial is to Evaluating Metformin Efficacy and Safety when Co-administered with Antiepileptic Drugs in Patients with Seizures. The main question it aims to answer is: * Does metformin have beneficial effect on epileptic patients? * How metformin can affect epileptic patient's health? Participants will be divided into 2 groups (control group and treatment group) * Control group will receive standard treatment (levetiracetam \&/or sodium valproate). * Treatment group will receive standard treatment (levetiracetam \&/or sodium valproate) + metformin

Conditions

• Epilepsy

Interventions

Type	Name	Description
DRUG	Levetiracetam &/or sodium valproate	levetiracetam \&/or sodium valproate will be given to 30 patients and monitored for 6 months
DRUG	Metformin	metformin + (levetiracetam \&/or sodium valproate) will be given to 30 patients and monitored for 6 months will be given to 30 patients and monitored for 6 months

Timeline

• Start date: 2022-10-18
• Primary completion: 2024-06-20
• Completion: 2024-06-20
• First posted: 2023-02-10
• Last updated: 2024-12-02

Locations

1 site across 1 country: Egypt